Dan Leonard analyst UBS

Currently out of the existing stock ratings of Dan Leonard, 141 are a BUY (59.49%), 77 are a HOLD (32.49%), 19 are a SELL (8.02%).

Dan Leonard

Work Performance Price Targets & Ratings Chart

Analyst Dan Leonard, currently employed at UBS, carries an average stock price target met ratio of 69.1% that have a potential upside of 19.53% achieved within 256 days.

Dan Leonard’s has documented 527 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.

Most recent stock forecast was given on WAT, Waters at 05-Aug-2026.

Wall Street Analyst Dan Leonard

Analyst best performing recommendations are on STVN (STEVANATO GROUP SPA).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 2/25/2026. The price target of $175 was fulfilled within 1 day with a profit of $7.44 (4.44%) receiving and performance score of 44.4.

Average potential price target upside

A Agilent Technologies AVTR Avantor BIO Bio-Rad Laboratories BRKR Bruker DHR Danaher EXAS EXACT Sciences GH Guardant Health HOLX Hologic ILMN Illumina IQV IQVIA Holdings MTD Mettler-Toledo International MYGN Myriad Genetics NTRA Natera NVTA Invitae Corp PKI PerkinElmer TECH Bio-Techne Corp TMO Thermo Fisher Scientific LH Laboratory of America Holdings WAT Waters CRL Charles River Laboratories DGX Quest Diagnostics FLDM Fluidigm ICLR ICON PLC QGEN Qiagen NV CERT Certara FLGT Fulgent Genetics MRVI Maravai Lifesciences Holdings  STVN Stevanato Group SpA ADPT Adaptive Biotechnologies Corp PROG Progenity LMNX Luminex RHP Ryman Hospitality Properties GHDX Genomic Health CYRX Cryoport TXG 10X Genomics LAB Standard Biotools ALR Alerislife CDNA Caredx HTGM HTG Molecular Diagnostics MEDP Medpace Holdings VCYT Veracyte WST West Pharmaceutical Services AA Alcoa Corp BDX Becton Dickinson and Company NVT nVent Electric PLC RGEN Repligen RVTY Revvity

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Jul-2026

$135

$-10.97 (-7.52%)

$180

Buy Since 06-Apr-2026

$148

$2.03 (1.39%)

$140

Buy Since 26-Feb-2026

$150

$4.03 (2.76%)

$145

Buy Since 02-Jun-2026

$155

$18.99 (13.96%)

$145

Buy Since 24-May-2023

$155

$9.03 (6.19%)

$165

Show more analysts

Please expand the browser size to see the chart

Which stock is Dan Leonard is most bullish on?

Potential upside of $68.14 has been obtained for WAT (WATERS)

Which stock is Dan Leonard is most reserved on?

Potential downside of -$102 has been obtained for CRL (CHARLES RIVER LABORATORIES)

What Year was the first public recommendation made by Dan Leonard?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?